A Rare Win for a Medical Testing Patent in Exergen Corporation v. Kaz USA, Inc.
a-rare-win-for-a-medical-test
A Rare Win for a Medical Testing Patent in Exergen Corporation v. Kaz USA, Inc. Read More »
Blog
New Study Affirms Exergen Temporal Artery Thermometry (TAT) Is Accurate for Preterm Neonates
WATERTOWN, Mass., April 24, 2018 (GLOBE NEWSWIRE) — A new study published in the Journal of Obstetric, Gynecologic, & Neonatal Nursing1 shows that Exergen temporal artery temperature measurements are as accurate as axillary temperature measurements in low-birth-weight neonates in the NICU. The study further affirms that nurses spent less time measuring with the temporal artery